892952-70-4 Usage
Uses
Used in Pharmaceutical Industry:
Tert-Butyl 4-(chloromethyl)thiazol-2-ylcarbamate is used as a pharmaceutical intermediate for the synthesis of various drugs and compounds. Its unique chemical structure and properties make it a valuable component in the development of new medications.
Used in Medicinal Chemistry:
As a thiazolyl carbamate derivative, Tert-Butyl 4-(chloromethyl)thiazol-2-ylcarbamate is used in medicinal chemistry for its potential applications in drug discovery. Its specific chemical properties allow it to be a promising candidate for the design and synthesis of novel therapeutic agents.
Used in Drug Development:
Tert-Butyl 4-(chloromethyl)thiazol-2-ylcarbamate is used as a building block in the development of new drugs. Its unique structure and reactivity contribute to the creation of innovative pharmaceutical compounds with potential therapeutic benefits.
Used in Research and Development:
This chemical compound is also used as a research tool in the study of biological processes. Its involvement in various chemical reactions and interactions with biological systems provides valuable insights into the mechanisms of drug action and potential therapeutic applications.
Check Digit Verification of cas no
The CAS Registry Mumber 892952-70-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,9,2,9,5 and 2 respectively; the second part has 2 digits, 7 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 892952-70:
(8*8)+(7*9)+(6*2)+(5*9)+(4*5)+(3*2)+(2*7)+(1*0)=224
224 % 10 = 4
So 892952-70-4 is a valid CAS Registry Number.
892952-70-4Relevant academic research and scientific papers
GLUCOKINASE ACTIVATORS AND METHODS OF USING SAME
-
Page/Page column 28; 29, (2018/02/28)
A compound, enantiomer, prodrug, diastereomer, or salt is provided which is an activator of the enzyme glucokinase and thus is believed to be useful in treating diabetes and related diseases, which compound has the structure (I). A method for treating diabetes and related disease employing the compound, enantiomer, prodrug, diastereomer, or salt is also provided.
ANTIBACTERIAL HETEROCYCLIC UREAS
-
Page/Page column 38, (2010/11/29)
The present invention provides novel heterocyclic urea compounds having useful antibacterial activity, pharmaceutical compositions comprising one or more of these compounds, methods of making the same, and methods of using the same.
